1. Home
  2. TEVA vs LH Comparison

TEVA vs LH Comparison

Compare TEVA & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • LH
  • Stock Information
  • Founded
  • TEVA 1901
  • LH 1971
  • Country
  • TEVA Israel
  • LH United States
  • Employees
  • TEVA N/A
  • LH N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • LH Medical Specialities
  • Sector
  • TEVA Health Care
  • LH Health Care
  • Exchange
  • TEVA Nasdaq
  • LH Nasdaq
  • Market Cap
  • TEVA 20.1B
  • LH 21.8B
  • IPO Year
  • TEVA N/A
  • LH N/A
  • Fundamental
  • Price
  • TEVA $16.72
  • LH $262.33
  • Analyst Decision
  • TEVA Strong Buy
  • LH Strong Buy
  • Analyst Count
  • TEVA 8
  • LH 15
  • Target Price
  • TEVA $24.50
  • LH $273.36
  • AVG Volume (30 Days)
  • TEVA 10.5M
  • LH 656.6K
  • Earning Date
  • TEVA 07-30-2025
  • LH 07-31-2025
  • Dividend Yield
  • TEVA N/A
  • LH 1.10%
  • EPS Growth
  • TEVA N/A
  • LH 73.29
  • EPS
  • TEVA N/A
  • LH 8.67
  • Revenue
  • TEVA $16,616,000,000.00
  • LH $13,177,400,000.00
  • Revenue This Year
  • TEVA $5.69
  • LH $10.03
  • Revenue Next Year
  • TEVA N/A
  • LH $4.82
  • P/E Ratio
  • TEVA N/A
  • LH $30.23
  • Revenue Growth
  • TEVA 3.82
  • LH 7.13
  • 52 Week Low
  • TEVA $12.47
  • LH $198.96
  • 52 Week High
  • TEVA $22.80
  • LH $264.03
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 44.93
  • LH 53.56
  • Support Level
  • TEVA $16.65
  • LH $258.49
  • Resistance Level
  • TEVA $17.31
  • LH $263.50
  • Average True Range (ATR)
  • TEVA 0.49
  • LH 4.46
  • MACD
  • TEVA -0.13
  • LH -0.66
  • Stochastic Oscillator
  • TEVA 0.00
  • LH 47.58

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About LH Laboratory Corporation of America Holdings

Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.

Share on Social Networks: